Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy

Cells. 2023 Jan 10;12(2):271. doi: 10.3390/cells12020271.

Abstract

Reactive oxygen species (ROS), which excessively arise in diabetes and systemic inflammatory diseases, modify cellular lipids and cellular lipid composition leading to altered biophysical properties of cellular membranes. The impact of lipid peroxidation on transmembrane signaling routes is not yet well studied. The canonical transient receptor potential channel 6 (TRPC6) is implicated in the pathogenesis of several forms of glomerular diseases. TRPC6 is sensitive to membrane stretch and relies on a distinct lipid environment. This study investigates the effect of oxidative alterations to plasma membrane lipids on TRPC6 activity and the function of the glomerular filter. Knockout of the anti-oxidative, lipid modifying enzyme paraoxonase 2 (PON2) leads to altered biophysical properties of glomerular epithelial cells, which are called podocytes. Cortical stiffness, quantified by atomic force microscopy, was largely increased in PON2-deficient cultured podocytes. PON2 deficiency markedly enhanced TRPC6 channel currents and channel recovery. Treatment with the amphiphilic substance capsazepine in micromolar doses reduced cortical stiffness and abrogated TRPC6 conductance. In in vivo studies, capsazepine reduced the glomerular phenotype in the model of adriamycin-induced nephropathy in PON2 knockout mice and wildtype littermates. In diabetic AKITA mice, the progression of albuminuria and diabetic kidney disease was delayed. In summary, we provide evidence that the modification of membrane characteristics affects TRPC6 signaling. These results could spur future research to investigate modification of the direct lipid environment of TRPC6 as a future therapeutic strategy in glomerular disease.

Keywords: glomerular disease; lipid peroxidation; oxidative stress; podocyte; proteinuria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capsaicin
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / metabolism
  • Doxorubicin / adverse effects
  • Mice
  • Mice, Knockout
  • TRPC Cation Channels / metabolism
  • TRPC6 Cation Channel
  • Transient Receptor Potential Channels*

Substances

  • TRPC6 Cation Channel
  • Transient Receptor Potential Channels
  • TRPC Cation Channels
  • Doxorubicin
  • capsazepine
  • Capsaicin
  • Trpc6 protein, mouse

Grants and funding

H.H. received funding from Marga Boll Foundation (HH 210-05-11), Else Kröner-Fresenius Foundation (2016_A62), the Köln Fortune Program of the University of Cologne, Germany, and the German Society of Nephrology (DGFN + Kidney Foundation-Scholarship). P.T.B. was supported by a DFG fellowship (BR2955/6-1) and the clinical research unit (KFO 329, BR 2955/8-1). Additional support was provided from the consortium STOP-FSGS by the Germany Ministry for Science and Education (BMBF 01GM1901E to P.T.B. and T.B.).